DOCSLIB.ORG

Discipline Type Discipline Description

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Discipline Type Discipline Description DISCIPLINE TREATMENT TREATMENT_ DISCIPLINE_DESCRIPTION TREATMENT_DESCRIPTION EFFECTIVE_START_DATE _TYPE _CODE PRICE 052 Pathology (Clinical) 0017 Subcutaneous Injection 180,14 2020/01/01 052 Pathology (Clinical) 0130 Telephone consultation (all hours) 285,64 2020/01/01 Subsequent Injections For the same condition administered by practitioners (reFer modiFier 0017) (not chargeable together 052 Pathology (Clinical) 0131 with any consultation item) 180,15 2020/01/01 052 Pathology (Clinical) 0173 First hospital consultation/visit oF an average duration and/or complexity. 404,58 2020/01/01 2020/01/01 052 Pathology (Clinical) 0174 First hospital consultation/visit oF a moderately above average duration and/or complexity. 404,58 052 Pathology (Clinical) 0175 First hospital consultation/visit oF long duration and/or high complexity. 404,58 2020/01/01 052 Pathology (Clinical) 0190 New and established patient: Consultation/visit oF new or established patient oF an average duration and/or complexity. 404,58 2020/01/01 New and established patient: Consultation/visit oF new or established patient oF a moderately above average duration and/or 052 Pathology (Clinical) 0191 complexity 404,58 2020/01/01 052 Pathology (Clinical) 0192 New and established patient: Consultation/visit oF new or established patient oF long duration and/or high complexity. 404,58 2020/01/01 052 Pathology (Clinical) 1204 Intensive care: Category 1 (High Care) : Cases requiring intensive monitoring: Per day 442,11 2020/01/01 Cardio-respiratory resuscitation: Prolonged attendance in cases oF emergency (not necessarily in ICU) - 50,00 clinical 052 Pathology (Clinical) 1211 procedure units per halF hour or part thereoF 2211,81 2020/01/01 052 Pathology (Clinical) 3705 Alkali resistant haemoglobin 76,74 2020/01/01 052 Pathology (Clinical) 3709 Antiglobulin test (Coombs or trypsinzied red cells) 62,13 2020/01/01 052 Pathology (Clinical) 3710 Antibody titration 122,74 2020/01/01 052 Pathology (Clinical) 3711 Arneth count 38,26 2020/01/01 052 Pathology (Clinical) 3712 Antibody identiFication 143,95 2020/01/01 052 Pathology (Clinical) 3713 Bleeding time (does not include the cost oF the simplate device) 118,21 2020/01/01 052 Pathology (Clinical) 3714 Blood volume, dye method 122,74 2020/01/01 052 Pathology (Clinical) 3715 BuFFy layer examination 339,05 2020/01/01 052 Pathology (Clinical) 3717 Bone marrow cytological examination only 339,05 2020/01/01 052 Pathology (Clinical) 3719 Bone marrow: Aspiration 143,01 2020/01/01 052 Pathology (Clinical) 3720 Bone marrow trephine biopsy 555,37 2020/01/01 052 Pathology (Clinical) 3721 Bone marrow aspiration and trephine biopsy (excluding histology) 626,93 2020/01/01 052 Pathology (Clinical) 3722 Capillary Fragility: Hess 34,47 2020/01/01 052 Pathology (Clinical) 3723 Circulating anticoagulants 99,63 2020/01/01 052 Pathology (Clinical) 3724 Coagulation Factor inhibitor assay 980,59 2020/01/01 052 Pathology (Clinical) 3726 Activated protein C resistance 442,84 2020/01/01 052 Pathology (Clinical) 3727 Coagulation time 53,78 2020/01/01 052 Pathology (Clinical) 3728 Anti-factor Xa Activity 913,16 2020/01/01 052 Pathology (Clinical) 3729 Cold agglutinins 61,38 2020/01/01 052 Pathology (Clinical) 3730 Protein S: Functional 638,90 2020/01/01 052 Pathology (Clinical) 3731 Compatibility For blood transfusion 61,38 2020/01/01 052 Pathology (Clinical) 3732 Cryoglobulin 61,38 2020/01/01 052 Pathology (Clinical) 3734 Protein C (chromogenic) 515,95 2020/01/01 052 Pathology (Clinical) 3735 Anti-thrombin III (chromogenic) 374,84 2020/01/01 052 Pathology (Clinical) 3736 Plasminogen (chromogenic) 1050,28 2020/01/01 052 Pathology (Clinical) 3737 Lupus Russel Viper method 289,61 2020/01/01 052 Pathology (Clinical) 3738 Lupus Kaolin Exner method 425,98 2020/01/01 052 Pathology (Clinical) 3739 Erythrocyte count 38,26 2020/01/01 052 Pathology (Clinical) 3740 Factors V and VII: Qualitative 122,74 2020/01/01 052 Pathology (Clinical) 3741 Coagulation Factor assay: Functional 161,02 2020/01/01 052 Pathology (Clinical) 3742 Coagulation Factor assay: Immunological 76,74 2020/01/01 052 Pathology (Clinical) 3743 Erythrocyte sedimentation rate 51,14 2020/01/01 052 Pathology (Clinical) 3744 Fibrin stabilizing Factor (urea test) 76,74 2020/01/01 052 Pathology (Clinical) 3746 Fibrin monomers 46,03 2020/01/01 052 Pathology (Clinical) 3748 Plasminogen activator inhibitor (PAI-I) 1123,57 2020/01/01 052 Pathology (Clinical) 3750 Tissue plasminogen Activator (tPA) 1154,82 2020/01/01 052 Pathology (Clinical) 3751 Osmotic Fragility (screen) 38,26 2020/01/01 052 Pathology (Clinical) 3752 Osmotic Fragility test: Quantitative 170,27 2020/01/01 052 Pathology (Clinical) 3753 Osmotic Fragility (beFore and aFter incubation) 306,67 2020/01/01 052 Pathology (Clinical) 3754 ABO Reverse Group 61,38 2020/01/01 052 Pathology (Clinical) 3755 Full blood count (including items 3739, 3762, 3783, 3785, 3791) 178,80 2020/01/01 052 Pathology (Clinical) 3756 Full cross match 122,74 2020/01/01 052 Pathology (Clinical) 3757 Coagulation Factors: Quantitative 548,52 2020/01/01 052 Pathology (Clinical) 3758 Factor VIII related antigen 1029,99 2020/01/01 052 Pathology (Clinical) 3759 Coagulation Factor correction study 199,67 2020/01/01 052 Pathology (Clinical) 3761 Factor XIII related antigen 1040,99 2020/01/01 052 Pathology (Clinical) 3762 Haemoglobin estimation 30,71 2020/01/01 052 Pathology (Clinical) 3763 Contact activated product assay 275,98 2020/01/01 052 Pathology (Clinical) 3764 Grouping: A B and O antigens 61,38 2020/01/01 052 Pathology (Clinical) 3765 Grouping: Rh antigen 61,38 2020/01/01 052 Pathology (Clinical) 3766 PIVKA 740,80 2020/01/01 052 Pathology (Clinical) 3767 Euglobulin Lysis time 435,84 2020/01/01 052 Pathology (Clinical) 3768 Haemoglobin A2 (column chromatography) 255,51 2020/01/01 052 Pathology (Clinical) 3769 Haemoglobin electrophoresis 456,85 2020/01/01 052 Pathology (Clinical) 3770 Haemoglobin-S (solubility test) 61,38 2020/01/01 052 Pathology (Clinical) 3771 Factor III-availability test 99,63 2020/01/01 052 Pathology (Clinical) 3772 Haptoglobin: Quantitative 161,02 2020/01/01 052 Pathology (Clinical) 3773 Ham s acidiFied serum test 136,40 2020/01/01 052 Pathology (Clinical) 3775 Heinz bodies 38,26 2020/01/01 052 Pathology (Clinical) 3776 Haemosiderin in urinary sediment 38,26 2020/01/01 052 Pathology (Clinical) 3781 Heparin tolerance 122,74 2020/01/01 052 Pathology (Clinical) 3783 Leucocyte diFFerential count 105,72 2020/01/01 052 Pathology (Clinical) 3785 Leucocytes: Total count 30,71 2020/01/01 052 Pathology (Clinical) 3786 QBC malaria concentration and Fluorescent staining 425,98 2020/01/01 052 Pathology (Clinical) 3787 LE-cells 141,50 2020/01/01 052 Pathology (Clinical) 3789 Neutrophil alkaline phosphatase 476,94 2020/01/01 052 Pathology (Clinical) 3791 Packed cell volume: Haematocrit 30,71 2020/01/01 052 Pathology (Clinical) 3792 Plasmodium Falciparum: Monoclonal immunological identiFication 153,23 2020/01/01 052 Pathology (Clinical) 3793 Plasma haemoglobin 114,99 2020/01/01 052 Pathology (Clinical) 3794 Platelet sensitivities 317,45 2020/01/01 052 Pathology (Clinical) 3795 Platelet aggregation per aggregant 206,86 2020/01/01 052 Pathology (Clinical) 3796 Platelet antibodies: Agglutination 92,07 2020/01/01 052 Pathology (Clinical) 3797 Platelet count 38,26 2020/01/01 052 Pathology (Clinical) 3799 Platelet adhesiveness 76,74 2020/01/01 052 Pathology (Clinical) 3801 Prothrombin consumption 99,63 2020/01/01 052 Pathology (Clinical) 3803 Prothrombin determination (two stages) 99,63 2020/01/01 052 Pathology (Clinical) 3805 Prothrombin index 102,28 2020/01/01 052 Pathology (Clinical) 3806 Therapeutic drug level: Dosage 76,74 2020/01/01 052 Pathology (Clinical) 3807 RecalciFication time 38,26 2020/01/01 052 Pathology (Clinical) 3809 Reticulocyte count 51,14 2020/01/01 052 Pathology (Clinical) 3810 Schumm s test 61,38 2020/01/01 052 Pathology (Clinical) 3811 Sickling test 38,26 2020/01/01 052 Pathology (Clinical) 3814 Sucrose lysis test For PNH 61,38 2020/01/01 052 Pathology (Clinical) 3816 T and B-cells EAC markers (limited to ONE marker only For CD4/8 counts) 359,49 2020/01/01 052 Pathology (Clinical) 3820 Thrombo - Elastogram 442,84 2020/01/01 052 Pathology (Clinical) 3825 Fibrinogen titre 61,38 2020/01/01 052 Pathology (Clinical) 3829 Glucose 6-phosphate-dehydrogenase: Qualitative 136,40 2020/01/01 052 Pathology (Clinical) 3830 Glucose 6-phosphate-dehydrogenase: Quantitative 272,56 2020/01/01 052 Pathology (Clinical) 3832 Red cell pyruvate kinase: Quantitative 272,56 2020/01/01 052 Pathology (Clinical) 3834 Red cell Rhesus phenotype 168,57 2020/01/01 052 Pathology (Clinical) 3835 Haemoglobin F in blood smear 99,63 2020/01/01 052 Pathology (Clinical) 3837 Partial thromboplastin time 99,63 2020/01/01 052 Pathology (Clinical) 3841 Thrombin time (screen) 122,00 2020/01/01 052 Pathology (Clinical) 3843 Thrombin time (serial) 130,34 2020/01/01 052 Pathology (Clinical) 3847 Haemoglobin H 38,26 2020/01/01 052 Pathology (Clinical) 3851 Fibrin degeneration products (diFFusion plate) 176,36 2020/01/01 052 Pathology (Clinical) 3853 Fibrin degeneration products (latex slide) 76,74 2020/01/01 052 Pathology (Clinical) 3854 XDP (Dimer test or equivalent latex slide test) 144,73 2020/01/01 052 Pathology (Clinical) 3855 Haemagglutination inhibition 168,57 2020/01/01 052 Pathology (Clinical) 3856 D-Dimer (quantitative) 468,78 2020/01/01 052 Pathology (Clinical) 3857 Ristocetin CoFactor 605,36 2020/01/01 052 Pathology (Clinical) 3858 Heparin removal 491,92 2020/01/01 052 Pathology (Clinical) 3863 Autogenous vaccine 214,61 2020/01/01 052 Pathology (Clinical) 3864 Entomological examination 352,67 2020/01/01 052 Pathology (Clinical) 3865 Parasites in blood smear 95,47 2020/01/01 052 Pathology (Clinical) 3867 Miscellaneous (body Fluids, urine, exudate, Fungi, puss, scrapings, etc.
Load more

Recommended publications
  • University of St Andrews
    University of St Andrews Full metadata for this thesis is available in St Andrews Research Repository at: http://research-repository.st-andrews.ac.uk/ This thesis is protected by original copyright ABSTRACT Early beliefs that Barr Bodies (sex chromatin; drumsticks) u/ere due merely to the XX Chromosomes in the female mere challenged as far back as 1956. That they only appear in a percentage of neutrophils, polymorphs and other somatic cells mas a starting point and that they are more frequent mhen nuclear segmentation is increased either by ageing or folate deficiency suggested that the explanation originally held required closer investigation. A great deal of research has been undertaken to establish the factors involved. Some account of these are listed and recorded in this thesis. The comparative incidence of Barr Bodies in mammalian blood appears to have little coverage and go round an aspect morthy of investigation. Apart from humans the range of available mammals was limited largely to domestic animals; although an attempt mas made (with small success) to obtain material from more exotic mammals. The range of the different groups (13 in all) is set out in the tables which includes mainly normal mammals with a small section on the megaloblastic anaemias as a readily available source of hypersegmentation associated with folate deficiency. The main difficulties encountered mere the limited time available; the difficulty in obtaining material in sufficient quantity to have numerical significance; the nature of this work which is very labour intensive in that it cannot successfully be automated in any of the aspects. UJithin the frame work of this thesis, there is scope for a very great deal of development which the writer intends to undertake on his required return home.
    [Show full text]
  • Climatic and Temporal Variations in the I Ii H I Normal
    CLIMATIC AND TEMPORAL VARIATIONS IN THE NORMAL POLMUCLSAR COUNT - A STUDY OF THE NEUTROPHIL POLTMORPHONUCLBAR LEUCOCYTES CONTENTS I Introduction p. 2 II Procedure p. 21 A. On Ships 60 . B* Ashore Part 1. Glasgow Part 2. Cambridge HI Analysis of Results p. 37 The Polynuclear Count and A. Body Temperature B.. Barometric Pressure C. Atmospheric Humidity D. The Effect of the Sea E. Solar Radiation P. External Temperature G. The Total and Differential White Blood Cell Count. IV Discussion p.56 The Polynuclear Count and Body Temperature, Barometric Pressure, Atmospheric Humidity and the Effect of the Sea* The Polynuclear Count and Solar Radiation. The Polynuclear Count and External Temperature. The Polynuclear Count and the Total and Differential White Blood Cell Count. The Mechanism of the Changes Observed in the White Blood Cells. V Summary p. 75 Appendix p.77 A* The Results p.,232 B» Graphical Representation of the Results p.233 C. Notes on the Calculation of Coefficients of Correlation. VII Bibliography p. 235 ProQuest Number: 13870153 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 13870153 Published by ProQuest LLC(2019). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC.
    [Show full text]
  • Erythronoclastic) Anaemias of Later Infancy and Childhood: with Special Reference to the Acute Heemolytic Anemia of Lederer and the Anvemia of Von Jaksch
    Arch Dis Child: first published as 10.1136/adc.8.45.184 on 1 June 1933. Downloaded from Part V.-The hamolytic (erythronoclastic) anaemias of later infancy and childhood: with special reference to the acute heemolytic anemia of Lederer and the anvemia of von Jaksch BY LEONARD G. PARSONS, M.D., F.R.C.P., AND J. C. HAWKSLEY, M.D., M.R.C.P. The destructive diseases of the erythron which fall for consideration under this heading show many points of general similarity although individual variations are frequent. In Part IV emphasis has been laid upon the fact that the erythron may be affected adversely either in the bone marrow or in the circulation; further, that for this reason the term haemolytic anaemia was probably incorrect because it stressed the destruction of red blood cells, but that the title of erythronoclastic ansemia was more correct http://adc.bmj.com/ because it indicated that the erythron may be affected in the circulation or in the marrow or in both situations. Moreover, this is not the whole story, because not only may the erythron itself be affected in either the circulation, the marrow or both, but also the other elements of the blood, the thrombocyte system and the myeloid leucocyte system, may suffer damage. in child's of iron Again, the latter months of the lactation period the supply on September 27, 2021 by guest. Protected copyright. for haemoglobin-building is somewhat precarious; a disturbance of the erythron is therefore likely to render manifest any iron deficiency and thus a deficiency anaemia may develop in the course of a haemolytic ansemia.
    [Show full text]
  • Chapter Preview
    A TEXT BOOK OF PHYSIOLOGY Dr. Pratiti Ghosh, FABMS Ex-Visiting Fellow, National Institutes of Health, USA. Associate Professor & Head Department of Physiology West Bengal State University Kolkata. MUMBAI NEW DELHI NAGPUR BENGALURU HYDERABAD CHENNAI PUNE LUCKNOW AHMEDABAD ERNAKULAM BHUBANESWAR INDORE KOLKATA GUWAHATI © Author No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording and/or otherwise without the prior written permission of the publisher. First Edition : 2015 Published by : Mrs. Meena Pandey for Himalaya Publishing House Pvt. Ltd., “Ramdoot”, Dr. Bhalerao Marg, Girgaon, Mumbai - 400 004. Phone: 022-23860170/23863863, Fax: 022-23877178 E-mail: [email protected]; Website: www.himpub.com Branch Offices : New Delhi : “Pooja Apartments”, 4-B, Murari Lal Street, Ansari Road, Darya Ganj, New Delhi - 110 002. Phone: 011-23270392, 23278631; Fax: 011-23256286 Nagpur : Kundanlal Chandak Industrial Estate, Ghat Road, Nagpur - 440 018. Phone: 0712-2738731, 3296733; Telefax: 0712-2721216 Bengaluru : No. 16/1 (Old 12/1), 1st Floor, Next to Hotel Highlands, Madhava Nagar, Race Course Road, Bengaluru - 560 001. Phone: 080-22286611, 22385461, 4113 8821, 22281541 Hyderabad : No. 3-4-184, Lingampally, Besides Raghavendra Swamy Matham, Kachiguda, Hyderabad - 500 027. Phone: 040-27560041, 27550139 Chennai : New-20, Old-59, Thirumalai Pillai Road, T. Nagar, Chennai - 600 017. Mobile: 9380460419 Pune : First Floor, "Laksha" Apartment, No. 527, Mehunpura, Shaniwarpeth (Near Prabhat Theatre), Pune - 411 030. Phone: 020-24496323/24496333; Mobile: 09370579333 Lucknow : House No 731, Shekhupura Colony, Near B.D. Convent School, Aliganj, Lucknow - 226 022. Phone: 0522-4012353; Mobile: 09307501549 Ahmedabad : 114, “SHAIL”, 1st Floor, Opp.
    [Show full text]
  • Pseudo-Pelger-Huët Anomaly in Megaloblastic Anemia
    International Blood Research & Reviews 7(3): 1-5, 2017; Article no.IBRR.34868 ISSN: 2321–7219 Pseudo-Pelger-Huët Anomaly in Megaloblastic Anemia Ajay Kumar Khandal1,2* 1Department of Medicine, Prathima Institute of Medical Sciences, Karimnagar, India. 2Usha Khandal Hospital, Mukarampura, Karimnagar, India. Author’s contribution The sole author designed, analyzed and interpreted and prepared the manuscript. Article Information DOI: 10.9734/IBRR/2017/34868 Editor(s): (1) Anamika Dhyani, Laboratory of Biochemistry & Molecular and Cellular Biology Hemocentro-UNICAMP, Brazil. Reviewers: (1) Neema Tiwari, Eras Lucknow Medical College and Hospital, India. (2) D. Atere Adedeji, Achievers University, Owo, Nigeria. (3) Susumu Inoue, Michigan State University College of Human Medicine, Michigan, USA. Complete Peer review History: http://www.sciencedomain.org/review-history/20294 Received 16th June 2017 Accepted 28th July 2017 Case Report st Published 31 July 2017 ABSTRACT The Pelger-Huët anomaly (PHA) is a morphologic abnormality of segmentation involving the neutrophils predominantly; however, all leucocytes may be variably affected; it is an autosomal dominant condition. It has a global prevalence; with certain Indian populations having a reported prevalence as high as 1 in 300. PHA should be considered when clinical labs suggest a profound left shift in the setting of normal leucocyte count. Clinically, PHA needs differentiation from the pseudo-Pelger-Huët anomaly (PPHA), which though morphologically similar is associated with multiple disease states such as; myelodysplasia, myeloproliferative disorders, leukemias, or drugs. PPHA with megaloblastic anemia is rarely seen. Reported herein, is a case of megaloblastic anemia with PPHA. Keywords: Pelger-Huët anomaly; pseudo–Pelger-Huët anomaly; myelodysplasia; megaloblastic anemia; vitamin B12 deficiency.
    [Show full text]
  • Atlas of Avian Hematology
    Atlas of Avian Hematology ALFRED M. LUCAS • CASIMIR JAMROZ Agriculture Monograph 25 UNITED STATES DEPARTMENT OF AGRICULTURE Marine Biological Laboratory Library Woods Hole. Massachusetts Gift of the Author - 1976 7. t/u JZt^^-w-y /7 -^^ I -0 m !_^ m U9 Atlas of Avian Hematology Alfred M. Lucas, A.B., Ph.D., Cytopathologist Casimir Jamroz, B.S., A.B., Medical Illustrator Regional Poultry Research Laboratory, East Lansing, Mich. Animal Husbandry Research Division Agricultural Research Service Agricuhiire Monograph 25 UNITED STATES DEPARTMENT OF AGRICULTURE WASHINGTON : 1961 For sale by the Superintendent of Documents, U.S. Government Prmting Office - Washington 25, D.C. Preface An atlas of hematology is a picture Itook that functions as a dictionary. Minot, in his foreword to Atlas of the Blood in Children, hy Blackfan, Dia- mond, and Leister (1944), aptly expressed the need for illustrations in hematology when he stated, "Illustration is essential in hematology. The in- adequacy of language to convey the appearance of disease to the mind renders an appeal to the senses desirable whenever it can be employed, and when the objects themselves cannot be presented the best substitute for them is to be found in pictures." It is hoped that this Atlas will enable investigators to forge ahead without the necessity for long delay in determining how the normal cell types and developmental stages should appear. The identification of the early and intermediate stages of development for most of the cell types has been worked out for the first time. The results of this research have been inte- grated with previous knowledge.
    [Show full text]
  • The Leucocytosis of Trauma
    Kom,A U '441+ 2807400595 THE LEUCOCYTOSIS OF TRAUMA ROBERT ANTHONY COCKS MD THESIS 1993 ■BEWCAL LIBRARY, îOYAL FREE HOSMTAi HAMPSTEAD, ProQuest Number: U075909 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest U075909 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 O/bfcO ABSTRACT The studies in this thesis have attempted to establish the existence of the leucocytosis of trauma, to clarify its features, and to examine its possible implications for the immune response. 110 patients were studied within three hours of moderate or major injury, and a significant difference (p<0.0001) established between their leucocyte counts and those of 110 normal controls. Differential leucocyte counts of 42 patients gave evidence of a very early neutrophilia and lymphocytosis. The neutrophilia was maximal at 3-4 hours post-injury and resolved slowly. The lymphocytosis resolved rapidly and was commonly replaced by lymphopenia. Serial phenotype studies of lymphocytes in 28 patients showed significant reductions (p<0.01) in total lymphocytes, CD4 and CDS lymphocytes between blood samples taken less than 4 hours and 12-24 hours after injury.
    [Show full text]
  • STUDIES on the ARNETH COUNT in a HOT CLIMATE. Thesis
    STUDIES ON THE ARNETH COUNT IN A HOT CLIMATE. Thesis submitted for the M.D. Glasgow by Ian'waoKay, M.S.* Ch.B., 1930, D.P.H., Flight Lieutenant, R.A.F. ProQuest Number: 13905518 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest 13905518 Published by ProQuest LLC(2019). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 4 8 1 0 6 - 1346 CONTENTS . 1. Introduction. 2.- The Neutrophil Bioture. 3. The Polynuolear Count in Health. 4. - The Neutrophil Ploture in Certain Diseases in 'Iraq. 5. Summary and Conclusions. 6. Bibliography. 7. Appendix of Tabulated Counts. fjfc v£ sruxi-icj.tnv' \ >- -?5*« tk. '•' t he ■•&&&&£ - -v - r< Introduction. Arneth (1904) was the first to suggest that the ordinary total and differential oo'unts did not give a sufficiently delicate indication of haematologioal changes. He demonstrated that there was significant change in the nuoleus of the polymorphonuclear leukocyte in patients suffering from infectious diseases and that the severity of toxaemia oould he gauged from this. The Arneth count has been developed along different lines by other workers, notably Cooke and Ponder (1927) and Schilling (1911), who formulated standards for olinioal application in health and in certain diseases.
    [Show full text]
  • A Cytological Study of the Costal Marrow of the Adult Horse and Cow M
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1945 A cytological study of the costal marrow of the adult horse and cow M. Lois Calhoun Iowa State College Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Animal Sciences Commons, and the Veterinary Medicine Commons Recommended Citation Calhoun, M. Lois, "A cytological study of the costal marrow of the adult horse and cow " (1945). Retrospective Theses and Dissertations. 13465. https://lib.dr.iastate.edu/rtd/13465 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright materia! had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand corner and continuing from left to right in equal sections with small overlaps.
    [Show full text]
  • Letter Sign Specialty Associated Conditions Descriptor Aaron Sign
    Associated Letter Sign Specialty Descriptor conditions epigastric pain with Aaron sign surgery appendicitis pressure on McBurney's point Graves' levator palpebrae Abadie's sign endocrinology disease superioris spasm Abadie's absence of pain on neurology tabes dorsalis symptom Achilles tendon pressure Abderhalden obstetrics pregnancy serum reaction;obsolete reaction infectious presence of arsenical Abelin reaction syphilis disease anti-syphilitic;obsolete quantitative cells and Addis count nephrology pyelonephritis casts in 24hr. urine dilated pupil, poorly ciliary nerve Adie pupil neurology reactive but with normal damage near accommodation thoracic outlet obliteration of radial Adson's sign vascular surgery syndrome pulse with manoeuvres neurology, Alexander's vestibular describes nystagmus in neurosurgery, law lesions vestibular lesions ENT tests for presence of vascular surgery, arterial supply palmar ulnar-radial Allen's test critical care[1] of the hand anastomosis (palmar arch) Apgar score obstetrics assess health of newborn Apley grind orthopaedic meniscal manoeuvres to elicit test surgery lesions knee pain Argyll neurosyphilis [ Robertson neurology light-near dissociation 2] pupils haematology, folate lobulation of neutrophil Arneth count nutrition deficiency nuclei extension of a blister to Asboe-Hansen dermatology bullae adjacent unblistered skin sign when pressed oestral reaction in mouse Aschheim– normal obstetrics injected with pregnant Zondek test pregnancy urine foci of interstitial rheumatology, rheumatic inflammatiuon
    [Show full text]
  • The Leukocytes and Platelets of a Marsupial, Trichosurus Vulpecula. a Comparative Morphological, Metrical and Cytochemical Study
    Arch. histol. jap., Vol. 34, No. 4 (1972) p. 311-360 Department of Anatomy and Histology, University of Adelaide, Adelaide, South Australia The Leukocytes and Platelets of a Marsupial, Trichosurus vulpecula. A Comparative Morphological, Metrical and Cytochemical Study R.A. BARBOUR Received February 3, 1972 Summary. The leukocytes and platelets of Trichosurus vulpecula are in many res- pects typically mammalian. Relatively unusual morphological features are paucity of granules in neutrophils, elongated form of eosinophil granules, abundance and uniformity of basophil granules, and, in monocytes, high frequency of irregular nuclei (some annular) and coarseness of chromatin. Mean leukocyte count per cmm was 13,380 and mean counts for individual cell types were: neutrophils 5,790, eosinophils 221, basophils 31, lymphocytes 6,720, monocytes 619. The last two of these are fairly high amongst mammals, those for eosinophils and basophils fairly low. The mean number of nuclear segments per neutrophil was 2.41, per eosinophil 1.34. Mean diameters (in μ) of cell types in stained smears were: neutrophils 13.00, eosino- phils 13.77, basophils 14.24, lymphocytes 10.32, monocytes 14.99. Most platelets are similar in size to human ones but large examples are more common. Neutrophil granules are coloured intensely by sudan black B, eosinophil granules less so. Basophils and platelets, and most monocytes and lymphocytes, are sudanophobic. Amylase-labile PAS-positive material is abundant in neutrophils; there is some in plate- lets and, probably, also in basophil cytoplasmic matrix. Basophil granules and the peri- phery of eosinophil granules exhibit amylase-resistant PAS-positivity. No peroxidase is demonstrable in leukocytes using o-tolidine as substrate, but with benzidine a positive reaction occurs in neutrophils and eosinophils.
    [Show full text]
  • Nedicnllnbomtory Technology the Official Publication of the New Zealand Institute of Medical Laboratory Technology
    JULY, 1967 THE NEW ZEALAND JOURNAL OF nedicnllnbomtory technology The Official Publication of the New Zealand Institute of Medical Laboratory Technology. Incorporated EDITOR John Case SUB-EDITORS: J. Rees, H. C. W. ·Shott ADVERTISING MANAGER: F. C. Kershaw JOURNAL REPRESENTATIVES: AUCKLAND: J. Holland CHRISTCHURCH: D. S. McConnell HAMILTON: M. G. Harper WELLINGTON: Dorothy Hitchcock VOLUME 21. No. 2. ii METRIX HEMOGLOBIN STANDARD ( CV ANMETHEMOGLOBIN) CERTIFIED BY For the determination of total hemoglobin by the cyanmethemoglobin method, yielding dependable reproducible values. A reliable reference standard for the preparation of the standard curve and the calibration of instruments. Each lot approved by the College of American Pathologists. A stable solution. v "»· ...... ·.Y.Y. Packages of six vials, v lOcc.size. One vial sufficient for establishment v of the standard cuJVe. v Optical density directly v proportional to concentra· !ion up to 20 gm % v Hemoglobin. ~ ~ . ..: ~ . ~ . ~ ~ . ~ . .. ··------------ Five years ago most labs in US.A. were still using otherthromboplastins. Today more than 800Jo have changed to SimplastU:i. WhyP Such changes are not made lightly. Each laboratory had its reasons: Dependability Simplastin's repro· time and trouble than the do-it• ducibility from vial to vial and lot to yourself procedures - and you lot is guaranteed. We make sure of couldn't make a finer thromboplastin reproducibility by rigidly controlling by any means. such factors as particle size and Economy Thanks to the no-waste number, pH, ionic strength, moisture vials (6 and 20-determination size, to content, temperature stability. We match your laboratory load), the standardize Simplastin against nor· skilled time saved by simple recon· mal and dicumarolized plasmas, stitution, and the less frequent calls against whole and dilute Diagnostic for "repeats", many laboratories find Plasma Warner·Chilcott and against that their cost per test is lower with other lots of Simplastin.
    [Show full text]